Obesity Category Still Hot: Mizuho's Jared Holz

Bloomberg Published Updated Economy
Sign in to save

Why it matters

Mizuho Securities' Jared Holz believes there may be another bid from Pfizer in the obesity category, citing indirect hints from the company.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Bullish Confidence 80% How confidence is read Impact: Moderate

Market impact analysis based on bullish sentiment with 80% confidence.

Evidence trail

Evidence
Source Bloomberg
Claim Obesity Category Still Hot: Mizuho's Jared Holz
AI inference Bullish · 80%
Generated 2025-11-04 23:51

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
6788

Original source

Jared Holz, Mizuho Securities Healthcare Equity Strategist, says he wouldn’t be surprised to see one more bid from Pfizer. He tells Katie Greifeld and Matt Miller on “The Close” that Pfizer made it clear without saying so directly that its latest attempt may not be the final one. (Source: Bloomberg)

Read the full article on Bloomberg

Original article published by Bloomberg on November 5, 2025. Analysis and insights provided by AnalystMarkets AI.

Related coverage